XILAM ANIMATION (ALXIL.PA) Fundamental Analysis & Valuation

EPA:ALXIL • FR0004034072

Current stock price

3.01 EUR
-0.04 (-1.31%)
Last:

This ALXIL.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. ALXIL.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALXIL has reported negative net income.
  • In the past year ALXIL had a positive cash flow from operations.
  • ALXIL had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years ALXIL had a positive operating cash flow.
ALXIL.PA Yearly Net Income VS EBIT VS OCF VS FCFALXIL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

1.2 Ratios

  • The Return On Assets of ALXIL (-31.10%) is worse than 79.59% of its industry peers.
  • With a Return On Equity value of -57.89%, ALXIL perfoms like the industry average, outperforming 40.82% of the companies in the same industry.
  • The Return On Invested Capital of ALXIL (2.20%) is better than 61.22% of its industry peers.
  • ALXIL had an Average Return On Invested Capital over the past 3 years of 2.87%. This is significantly below the industry average of 8.28%.
Industry RankSector Rank
ROA -31.1%
ROE -57.89%
ROIC 2.2%
ROA(3y)-7.65%
ROA(5y)-3.34%
ROE(3y)-13.96%
ROE(5y)-5.53%
ROIC(3y)2.87%
ROIC(5y)3.58%
ALXIL.PA Yearly ROA, ROE, ROICALXIL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • ALXIL has a better Operating Margin (10.78%) than 73.47% of its industry peers.
  • In the last couple of years the Operating Margin of ALXIL has declined.
  • Looking at the Gross Margin, with a value of 94.08%, ALXIL belongs to the top of the industry, outperforming 87.76% of the companies in the same industry.
  • ALXIL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.78%
PM (TTM) N/A
GM 94.08%
OM growth 3Y-29.09%
OM growth 5Y-22.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y-0.8%
ALXIL.PA Yearly Profit, Operating, Gross MarginsALXIL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

3

2. ALXIL.PA Health Analysis

2.1 Basic Checks

  • ALXIL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for ALXIL has been increased compared to 1 year ago.
  • Compared to 5 years ago, ALXIL has more shares outstanding
  • The debt/assets ratio for ALXIL has been reduced compared to a year ago.
ALXIL.PA Yearly Shares OutstandingALXIL.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALXIL.PA Yearly Total Debt VS Total AssetsALXIL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • ALXIL has an Altman-Z score of 1.06. This is a bad value and indicates that ALXIL is not financially healthy and even has some risk of bankruptcy.
  • ALXIL's Altman-Z score of 1.06 is in line compared to the rest of the industry. ALXIL outperforms 55.10% of its industry peers.
  • The Debt to FCF ratio of ALXIL is 2.63, which is a good value as it means it would take ALXIL, 2.63 years of fcf income to pay off all of its debts.
  • ALXIL has a better Debt to FCF ratio (2.63) than 69.39% of its industry peers.
  • ALXIL has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.10, ALXIL belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 2.63
Altman-Z 1.06
ROIC/WACC0.35
WACC6.21%
ALXIL.PA Yearly LT Debt VS Equity VS FCFALXIL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 0.51 indicates that ALXIL may have some problems paying its short term obligations.
  • With a Current ratio value of 0.51, ALXIL is not doing good in the industry: 81.63% of the companies in the same industry are doing better.
  • ALXIL has a Quick Ratio of 0.51. This is a bad value and indicates that ALXIL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.51, ALXIL is doing worse than 81.63% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.51
ALXIL.PA Yearly Current Assets VS Current LiabilitesALXIL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2

3. ALXIL.PA Growth Analysis

3.1 Past

  • ALXIL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -974.67%.
  • ALXIL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -51.43%.
  • ALXIL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.01% yearly.
EPS 1Y (TTM)-974.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-165.84%
Revenue 1Y (TTM)-51.43%
Revenue growth 3Y-4.45%
Revenue growth 5Y1.01%
Sales Q2Q%-63.69%

3.2 Future

  • The Earnings Per Share is expected to grow by 26.58% on average over the next years. This is a very strong growth
  • The Revenue is expected to decrease by -4.82% on average over the next years.
EPS Next Y83.61%
EPS Next 2Y39.79%
EPS Next 3Y26.58%
EPS Next 5YN/A
Revenue Next Year-36.88%
Revenue Next 2Y-17.07%
Revenue Next 3Y-4.82%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALXIL.PA Yearly Revenue VS EstimatesALXIL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
ALXIL.PA Yearly EPS VS EstimatesALXIL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4

3

4. ALXIL.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALXIL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALXIL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALXIL.PA Price Earnings VS Forward Price EarningsALXIL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

  • ALXIL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ALXIL is cheaper than 100.00% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ALXIL is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.38
EV/EBITDA 0.62
ALXIL.PA Per share dataALXIL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALXIL's earnings are expected to grow with 26.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.79%
EPS Next 3Y26.58%

0

5. ALXIL.PA Dividend Analysis

5.1 Amount

  • ALXIL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ALXIL.PA Fundamentals: All Metrics, Ratios and Statistics

XILAM ANIMATION

EPA:ALXIL (3/13/2026, 7:00:00 PM)

3.01

-0.04 (-1.31%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)02-12
Earnings (Next)07-14
Inst Owners9.75%
Inst Owner ChangeN/A
Ins Owners42.6%
Ins Owner ChangeN/A
Market Cap17.73M
Revenue(TTM)16.11M
Net Income(TTM)-27.14M
Analysts42.22
Price Target3.67 (21.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.72%
PT rev (3m)6.72%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.89%
EPS NY rev (3m)-9.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.69%
Revenue NY rev (3m)1.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.1
P/FCF 5.38
P/OCF 1.01
P/B 0.38
P/tB N/A
EV/EBITDA 0.62
EPS(TTM)-4.59
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)0.56
FCFY18.59%
OCF(TTM)2.98
OCFY99.14%
SpS2.73
BVpS7.96
TBVpS-3.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.1%
ROE -57.89%
ROCE 2.99%
ROIC 2.2%
ROICexc 2.2%
ROICexgc N/A
OM 10.78%
PM (TTM) N/A
GM 94.08%
FCFM 20.45%
ROA(3y)-7.65%
ROA(5y)-3.34%
ROE(3y)-13.96%
ROE(5y)-5.53%
ROIC(3y)2.87%
ROIC(5y)3.58%
ROICexc(3y)3.22%
ROICexc(5y)4%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.91%
ROCE(5y)4.89%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-20.11%
ROICexc growth 5Y-18.18%
OM growth 3Y-29.09%
OM growth 5Y-22.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.96%
GM growth 5Y-0.8%
F-Score3
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 2.63
Debt/EBITDA 0.11
Cap/Depr 35%
Cap/Sales 88.66%
Interest Coverage 4.57
Cash Conversion 41.31%
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.51
Altman-Z 1.06
F-Score3
WACC6.21%
ROIC/WACC0.35
Cap/Depr(3y)71.92%
Cap/Depr(5y)106.47%
Cap/Sales(3y)53.47%
Cap/Sales(5y)81.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-974.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-165.84%
EPS Next Y83.61%
EPS Next 2Y39.79%
EPS Next 3Y26.58%
EPS Next 5YN/A
Revenue 1Y (TTM)-51.43%
Revenue growth 3Y-4.45%
Revenue growth 5Y1.01%
Sales Q2Q%-63.69%
Revenue Next Year-36.88%
Revenue Next 2Y-17.07%
Revenue Next 3Y-4.82%
Revenue Next 5YN/A
EBIT growth 1Y31.59%
EBIT growth 3Y-32.24%
EBIT growth 5Y-21.22%
EBIT Next Year122.48%
EBIT Next 3Y35.84%
EBIT Next 5YN/A
FCF growth 1Y-74.87%
FCF growth 3YN/A
FCF growth 5Y6.64%
OCF growth 1Y-51.48%
OCF growth 3Y-11.63%
OCF growth 5Y-8.76%

XILAM ANIMATION / ALXIL.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of XILAM ANIMATION (ALXIL.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALXIL.PA.


What is the valuation status for ALXIL stock?

ChartMill assigns a valuation rating of 3 / 10 to XILAM ANIMATION (ALXIL.PA). This can be considered as Overvalued.


What is the profitability of ALXIL stock?

XILAM ANIMATION (ALXIL.PA) has a profitability rating of 4 / 10.


How financially healthy is XILAM ANIMATION?

The financial health rating of XILAM ANIMATION (ALXIL.PA) is 3 / 10.